Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study.
Saved in:
| Title: | Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study. |
|---|---|
| Authors: | Superdock MA; Department of Medicine, Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Rimsza LM; Department of Pathology and Laboratory Medicine, The University of Arizona, Tucson, AZ, USA., Wallace DS; Department of Medicine, Division of Hematology and Oncology, University of Rochester Medical Center James P. Wilmot Cancer Institute, Rochester, NY, USA., Strawderman M; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA., Ramsower CA; Department of Pathology and Laboratory Medicine, The University of Arizona, Tucson, AZ, USA., Steiner RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Faugh T; Department of Medicine, Division of Hematology and Oncology, University of Rochester Medical Center James P. Wilmot Cancer Institute, Rochester, NY, USA., Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Link BK; Department of Internal Medicine, Division of Hematology, Oncology, and Bone & Marrow Transplantation, University of Iowa, Iowa City, IA, USA., Rosenthal AC; Department of Internal Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA., Burack WR; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA., Syrbu SI; Department of Pathology, University of Iowa, Iowa City, IA, USA., Feldman AL; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN, USA., Rock PJ; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA., Robetorye RS; Department of Laboratory Medicine & Pathology, Mayo Clinic, Phoenix, AZ, USA., Cerhan JR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Friedberg JW; Department of Medicine, Division of Hematology and Oncology, University of Rochester Medical Center James P. Wilmot Cancer Institute, Rochester, NY, USA., Casulo C; Department of Medicine, Division of Hematology and Oncology, University of Rochester Medical Center James P. Wilmot Cancer Institute, Rochester, NY, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2025 Dec; Vol. 66 (12), pp. 2324-2327. Date of Electronic Publication: 2025 Aug 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2025.2539231 |
